• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Cardiac Arrest (1762); Intracranial Hemorrhage (1891); Low Blood Pressure/ Hypotension (1914)
Event Date 11/28/2022
Event Type  Injury  
Event Description
It was reported that an air embolism occurred.A left atrial appendage (laa) closure procedure was being performed.A watchman access system (was), a watchman flx laa closure device & delivery system (wds), and a versacross connect laac access solution and nrg rf transseptal needle were selected to be used.The physician performed the transseptal puncture and then inserted the was.With the was positioned in the laa of the patient the wds was inserted.The physician deployed a 24mm closure device, but it did not meet release criteria.The device was fully recaptured and removed from the patient.A new transseptal puncture was performed at a more inferior position.After more than 20 minutes of trying the physician finally succeeded in achieving a new transseptal position.The physician positioned the was in the laa of the patient and continued the procedure.At this point in the procedure the patient's blood pressure began to drop, a perforation was ruled out, but the patient still decompensated.The patient was noted to have an av block and they went into cardiac arrest.Cardiopulmonary resuscitation was performed, and the patient was given epinephrine.After three minutes the patient's pulse returned.After an additional ten minutes while the patient remained stable the physician decided to continue the procedure.Before the procedure could be continued the patient decompensated a second time.The patient's blood pressured dropped again and the patient was given medication before becoming stable again.The physician ended the procedure with no closure device implanted and the patient will be kept overnight for observation.That night the patient experienced a cerebral vascular accident.A computed tomography scan was performed, and a subarachnoid hemorrhage was found.The patient is currently still hospitalized in the intensive care unit and is not responsive.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on
CA  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17624647
MDR Text Key321965197
Report Number2124215-2023-45855
Device Sequence Number1
Product Code DRE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/28/2022
Initial Date FDA Received08/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention; Disability;
Patient Age68 YR
Patient SexFemale
Patient Weight69 KG
Patient RaceBlack Or African American
-
-